Xenetic Biosciences, Inc.XBIONASDAQ
Loading
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | 26.67% |
| Q2 2025 | 23.73% |
| Q1 2025 | 13.24% |
| Q4 2024 | -142.86% |
| Q3 2024 | 66.27% |
| Q2 2024 | -6.41% |
| Q1 2024 | -2.63% |
| Q4 2023 | -10.14% |
| Q3 2023 | 0.00% |
| Q2 2023 | -30.19% |
| Q1 2023 | 41.76% |
| Q4 2022 | -51.67% |
| Q3 2022 | 71.15% |
| Q2 2022 | -71.90% |
| Q1 2022 | 32.78% |
| Q4 2021 | -35.34% |
| Q3 2021 | -2.31% |
| Q2 2021 | 15.58% |
| Q1 2021 | 3.14% |
| Q4 2020 | 86.76% |
| Q3 2020 | -690.13% |
| Q2 2020 | 19.58% |
| Q1 2020 | 26.74% |
| Q4 2019 | 88.80% |
| Q3 2019 | -47.50% |
| Q2 2019 | 5.05% |
| Q1 2019 | 22.73% |
| Q4 2018 | 7.92% |
| Q3 2018 | 16.83% |
| Q2 2018 | -10.80% |
| Q1 2018 | -140.88% |
| Q4 2017 | 297.65% |
| Q3 2017 | 22.82% |
| Q2 2017 | 0.35% |
| Q1 2017 | -7240.00% |
| Q4 2016 | 98.33% |
| Q3 2016 | 95.51% |
| Q2 2016 | -686.89% |
| Q1 2016 | -884.70% |
| Q4 2015 | 93.72% |